Cover Image

Recent progress in targeted therapy for non-small cell lung cancer

The high morbidity and mortality of non-small cell lung cancer (NSCLC) have always been major threats to people's health. With the identification of carcinogenic drivers in non-small cell lung cancer and the clinical application of targeted drugs, the prognosis of non-small cell lung cancer pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanxia Xiao (Author), Pu Liu (Author), Jie Wei (Author), Xin Zhang (Author), Jun Guo (Author), Yajun Lin (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer
by: Jiayi Shen, et al.
Published: (2024)

Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer
by: Zhuang HQ, et al.
Published: (2014)

Glycyrrhizin arginine salt protects against cisplation-induced acute liver injury by repressing BECN1-mediated ferroptosis
by: Jun Guo, et al.
Published: (2023)

Supramolecular self-assembly of a hybrid 'hyalurosome' for targeted photothermal therapy in non-small cell lung cancer
by: Haipeng Xu, et al.
Published: (2020)

Pristimerin inhibits thioredoxin reductase in the treatment of non-small cell lung cancer
by: Yajun Chu, et al.
Published: (2024)

Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
by: Wei Ye, et al.
Published: (2023)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
by: Jingsi Dong, et al.
Published: (2019)

Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies
by: Parth Malik, et al.
Published: (2023)

Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments
by: Chetna Gupta, et al.
Published: (2022)

Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma
by: Kaikai Gong, et al.
Published: (2020)

Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
Published: (2021)

miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1
by: Qi Song, et al.
Published: (2018)

Targeting glycolysis in non-small cell lung cancer: Promises and challenges
by: Jia-Qi Xu, et al.
Published: (2022)

Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy
by: Yaqin Tang, et al.
Published: (2023)

Next Generation of Advanced Non-Small Cell Lung Cancer Therapy: Targeted and Immuno-Therapies
by: Sze Wah Samuel Chan, et al.
Published: (2020)

Sintilimab for the treatment of non-small cell lung cancer
by: Lin Zhang, et al.
Published: (2022)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
by: Wenliang Liu, et al.
Published: (2022)

Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
by: Le AD, et al.
Published: (2017)

Kaempferol Protects Blood Vessels From Damage Induced by Oxidative Stress and Inflammation in Association With the Nrf2/HO-1 Signaling Pathway
by: He Yao, et al.
Published: (2020)

Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo
by: Ying Wang, et al.
Published: (2021)

Recent Progress of Copper-Based Nanomaterials in Tumor-Targeted Photothermal Therapy/Photodynamic Therapy
by: Xiqian Zhuo, et al.
Published: (2023)

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
by: Hang Yan, et al.
Published: (2022)

Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors
by: Ana P. S. Silva, et al.
Published: (2017)

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
by: Ioannis A. Vathiotis, et al.
Published: (2021)

Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
by: Arwa Omar Al Khatib, et al.
Published: (2023)

Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non‐small cell lung cancer with sensitive EGFR mutations
by: Yun Zhang, et al.
Published: (2021)

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non-Small Cell Lung Cancer
by: Dehua Liao, et al.
Published: (2022)

Prediction and validation of common targets in atherosclerosis and non-small cell lung cancer influenced by atorvastatin
by: Yu-qian Li, et al.
Published: (2023)

Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond
by: Xin Li, et al.
Published: (2024)

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States
by: Wentao Tian, et al.
Published: (2024)

Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer
by: Bingjie Wang, et al.
Published: (2019)

Editorial: Recent advances in small molecule-based targeted therapy for breast cancer
by: Thet Thet Htar, et al.
Published: (2023)

A Bibliometric Analysis of Triptolide and the Recent Advances in Treating Non-Small Cell Lung Cancer
by: Quancheng Yang, et al.
Published: (2022)

Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
by: Hongxing Yang, et al.
Published: (2022)

Recent progress in LyP-1-based strategies for targeted imaging and therapy
by: Ningning Song, et al.
Published: (2019)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
by: Ming Li, et al.
Published: (2021)

Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer
by: Lv J, et al.
Published: (2024)

Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis
by: Xie Mengyan, et al.
Published: (2022)

Exploring targets and related mechanisms of Scutellaria baicalensis for treating non-small cell lung cancer based on network pharmacology
by: Yuehong Luo, et al.
Published: (2024)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
by: Yan Hu, et al.
Published: (2022)